Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-986141 on Thrombus Formation in CAD and Healthy Participants
NCT05093790Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bms-986141 in coronary artery disease (CAD), sponsored by Bristol Myers Squibb. Started Mar 2022; status: completed.
02
Drugs
bms-986141
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05093790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05093790.